Brenda Lormil

NPI: 1306290234
Total Payments
$3,664
2024 Payments
$1,141
Companies
2
Transactions
5
Medicare Patients
202
Medicare Billing
$33,419

Payment Breakdown by Category

Consulting$3,608 (98.5%)
Food & Beverage$56.02 (1.5%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $3,608 3 98.5%
Food and Beverage $56.02 2 1.5%

Top Paying Companies

Company Total Records Latest Year
Novartis Pharmaceuticals Corporation $3,608 3 $0 (2024)
Genentech, Inc. $56.02 2 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,141 2 Novartis Pharmaceuticals Corporation ($1,110)
2023 $2,498 2 NOVARTIS PHARMACEUTICALS CORPORATION ($2,498)
2021 $24.87 1 Genentech, Inc. ($24.87)

All Payment Transactions

5 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
07/15/2024 Genentech, Inc. Phesgo Food and Beverage In-kind items and services $31.15 General
04/18/2024 Novartis Pharmaceuticals Corporation PLUVICTO (Drug) Consulting Fee Cash or cash equivalent $1,110.00 General
Category: Oncology
11/13/2023 NOVARTIS PHARMACEUTICALS CORPORATION Consulting Fee Cash or cash equivalent $740.00 General
09/22/2023 NOVARTIS PHARMACEUTICALS CORPORATION Consulting Fee Cash or cash equivalent $1,757.50 General
11/22/2021 Genentech, Inc. TECENTRIQ (Biological) Food and Beverage In-kind items and services $24.87 General
Category: BioOncology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 2 79 130 $61,868 $10,722
2022 1 32 73 $29,207 $5,106
2021 1 56 177 $59,140 $12,558
2020 1 35 91 $28,889 $5,034
Total Patients
202
Total Services
471
Medicare Billing
$33,419
Procedure Codes
5

All Medicare Procedures & Services

5 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 47 82 $33,116 $5,762 17.4%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2023 32 48 $28,752 $4,959 17.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 32 73 $29,207 $5,106 17.5%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 56 177 $59,140 $12,558 21.2%
99214 Established patient office or other outpatient, visit typically 25 minutes Facility 2020 35 91 $28,889 $5,034 17.4%

About Brenda Lormil

Brenda Lormil is a Family healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/18/2016. The National Provider Identifier (NPI) number assigned to this provider is 1306290234.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Brenda Lormil has received a total of $3,664 in payments from pharmaceutical and medical device companies, with $1,141 received in 2024. These payments were reported across 5 transactions from 2 companies. The most common payment nature is "Consulting Fee" ($3,608).

As a Medicare-enrolled provider, Lormil has provided services to 202 Medicare beneficiaries, totaling 471 services with total Medicare billing of $33,419. Data is available for 4 years (2020–2023), covering 5 distinct procedure/service records.

Practice Information

  • Specialty Family
  • Location Boston, MA
  • Active Since 04/18/2016
  • Last Updated 04/18/2016
  • Taxonomy Code 363LF0000X
  • Entity Type Individual
  • NPI Number 1306290234

Products in Payments

  • PLUVICTO (Drug) $1,110
  • TECENTRIQ (Biological) $24.87

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Doctors in Boston